Pfizer – Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited Settings – Request for Proposals

Well-being, Health and Biomedical Discovery


Academic Unit: Inquire within your unit

Memorial Deadline: Monday 23rd, August 2021

External Deadline: Thursday 26th, August 2021


Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. One such strategic priority is decreasing the disproportionate burden of poor health outcomes faced by patients who receive healthcare in resource limited settings, specifically to address health inequities relating to treatment of infectious diseases.

Global Bridges Healthcare Alliance, based at Mayo Clinic, is dedicated to supporting global communities of practice to advance evidence-based patient care. Since 2014, Global Bridges has worked collaboratively with Pfizer GMG to support medical education and quality improvement programs in multiple clinical areas, including tobacco dependence treatment, oncology, amyloidosis, and anti-microbial stewardship.

A pre-application webinar to answer questions will be held via WebEx on Wednesday, July28, 2021 at 10am EDT. Register using this link.

Proposals must be completed in the CyberGrants system no later than 5:00pm New York time on Thursday, 26th August 2021. Applications received after this date will not be reviewed.

Additional information can be found here.

Funding Sources

Pfizer Inc

This opportunity was posted by: RGCS

Last modified: July 15, 2021